Mirtazapine has 50 known drug interactions based on U.S. FDA drug labeling data. Of these, 7 are contraindicated combinations that should be avoided entirely. 27 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Isocarboxazid, Linezolid, Methylene Blue. Patients taking Mirtazapine should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 50
- Contraindicated
- 7
- Major
- 27
- Moderate
- 16
Contraindicated (7)
- Mirtazapine + Isocarboxazid— Concomitant use increases risk of serotonin syndrome. Mirtazapine is contraindicated in patients taking MAOIs.
- Mirtazapine + Linezolid— Concomitant use increases risk of serotonin syndrome. Mirtazapine is contraindicated in patients taking this MAOI.
- Mirtazapine + Methylene Blue— Intravenous methylene blue increases risk of serotonin syndrome. Mirtazapine is contraindicated in patients taking this …
- Mirtazapine + Monoamine Oxidase Inhibitors (Maois)— Monoamine Oxidase Inhibitors are contraindicated with mirtazapine; see contraindications, warnings, and dosage sections.
- Mirtazapine + Phenelzine— Concomitant use increases risk of serotonin syndrome. Mirtazapine is contraindicated in patients taking MAOIs.
- Mirtazapine + Selegiline— Concomitant use increases risk of serotonin syndrome. Mirtazapine is contraindicated in patients taking MAOIs.
- Mirtazapine + Tranylcypromine— Concomitant use increases risk of serotonin syndrome. Mirtazapine is contraindicated in patients taking MAOIs.
Major (27)
- Mirtazapine + Amitriptyline— Tricyclic antidepressant that increases risk of serotonin syndrome with mirtazapine. Monitor for symptoms during initiat…
- Mirtazapine + Amphetamine— Concomitant use increases risk of serotonin syndrome. Monitor for signs and symptoms, particularly during initiation and…
- Mirtazapine + Atropa Belladonna And Opium— Concomitant use may result in serotonin syndrome. Patient requires careful observation, particularly during initiation a…
- Mirtazapine + Buspirone— Concomitant use increases risk of serotonin syndrome. Monitor for signs and symptoms, particularly during initiation and…
- Mirtazapine + Diazepam— Diazepam Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in …
- Mirtazapine + Duloxetine— SNRI concomitant use increases risk of serotonin syndrome. Monitor for signs/symptoms; consider discontinuation if serot…
- Mirtazapine + Fentanyl— Concomitant use increases risk of serotonin syndrome. Monitor for signs and symptoms, particularly during initiation and…
- Mirtazapine + Fluoxetine— SSRI that increases risk of serotonin syndrome with mirtazapine. Monitor for symptoms during initiation and dose increas…
- Mirtazapine + Hydrocodone Bitartrate And Acetaminophen— Concomitant use has resulted in serotonin syndrome; carefully observe patient during treatment initiation and dose adjus…
- Mirtazapine + Hydromorphone Hydrochloride— Concomitant use may result in serotonin syndrome. Frequently evaluate patient during treatment initiation and dose adjus…
- Mirtazapine + Levorphanol Tartrate— Concomitant use has resulted in serotonin syndrome.
- Mirtazapine + Lithium— Concomitant use increases risk of serotonin syndrome. Monitor for signs and symptoms, particularly during initiation and…
- Mirtazapine + Metaxalone— Concomitant use may result in serotonin syndrome. Carefully observe patient during treatment initiation and dosage modif…
- Mirtazapine + Morphine Sulfate— Concomitant use can result in serotonin syndrome. Requires frequent patient evaluation, particularly during initiation a…
- Mirtazapine + Nalbuphine Hydrochloride— Concomitant use may result in serotonin syndrome. Carefully observe patient during treatment initiation and dose adjustm…
- Mirtazapine + Oxymorphone Hydrochloride— Serotonergic drug that may result in serotonin syndrome when used concomitantly.
- Mirtazapine + Paroxetine— SSRI that increases risk of serotonin syndrome with mirtazapine. Monitor for symptoms during initiation and dose increas…
- Mirtazapine + Pentazocine Hydrochloride And Naloxone Hydrochloride— Concomitant use has resulted in serotonin syndrome. Carefully observe patient during treatment initiation and dose adjus…
- Mirtazapine + Remifentanil Hydrochloride— Concomitant use may result in serotonin syndrome.
- Mirtazapine + Sertraline— SSRI that increases risk of serotonin syndrome with mirtazapine. Monitor for symptoms during initiation and dose increas…
- Mirtazapine + St. John'S Wort— Concomitant use increases risk of serotonin syndrome. Monitor for signs and symptoms, particularly during initiation and…
- Mirtazapine + Sumatriptan— Triptan that increases risk of serotonin syndrome with mirtazapine. Monitor for symptoms during initiation and dose incr…
- Mirtazapine + Tapentadol Hydrochloride— Concomitant use may result in serotonin syndrome. Frequent patient evaluation is recommended during initiation and dose …
- Mirtazapine + Tramadol— Concomitant use increases risk of serotonin syndrome. Monitor for signs and symptoms, particularly during initiation and…
- Mirtazapine + Triptans— Concomitant use increases risk of serotonin syndrome. Monitor for signs and symptoms, particularly during treatment init…
- Mirtazapine + Tryptophan— Concomitant use increases risk of serotonin syndrome. Monitor for signs and symptoms, particularly during initiation and…
- Mirtazapine + Venlafaxine— SNRI that increases risk of serotonin syndrome with mirtazapine. Monitor for symptoms during initiation and dose increas…
Moderate (16)
- Mirtazapine + Alcohol— Concomitant use increases impairment of cognitive and motor skills. Avoid concomitant use.
- Mirtazapine + Alprazolam— Benzodiazepine increases impairment of cognitive and motor skills. Avoid concomitant use.
- Mirtazapine + Azole Antifungals— Azole antifungals are potent CYP3A4 inhibitors that may increase mirtazapine concentrations. Caution should be exercised…
- Mirtazapine + Butorphanol Tartrate— Concomitant use may result in serotonin syndrome; monitor regularly during initiation and dose adjustment.
- Mirtazapine + Carbamazepine— Strong CYP3A inducer decreases mirtazapine plasma concentration. May require dose increase.
- Mirtazapine + Cimetidine— CYP1A2, CYP2D6, and CYP3A inhibitor may increase mirtazapine plasma concentration. May require dose decrease.
- Mirtazapine + Erythromycin— Caution should be exercised when coadministering mirtazapine with potent CYP3A4 inhibitors, HIV protease inhibitors, azo…
- Mirtazapine + Itraconazole— Strong CYP3A inhibitor may increase mirtazapine plasma concentration. May require dose decrease.
- Mirtazapine + Ketoconazole— Ketoconazole increases mirtazapine peak plasma levels by approximately 40% and AUC by 50%. Caution should be exercised w…
- Mirtazapine + Nefazodone— Strong CYP3A inhibitor may increase mirtazapine plasma concentration. May require dose decrease.
- Mirtazapine + Nitrazepam— Concomitant use increases impairment of cognitive and motor skills. Avoid concomitant use.
- Mirtazapine + Phenytoin— Strong CYP3A inducer decreases mirtazapine plasma concentration. May require dose increase.
- Mirtazapine + Protease Inhibitors— HIV protease inhibitors are potent CYP3A4 inhibitors that may increase mirtazapine concentrations. Caution should be exe…
- Mirtazapine + Rifampin— Strong CYP3A inducer decreases mirtazapine plasma concentration. May require dose increase.
- Mirtazapine + Ritonavir— Strong CYP3A inhibitor may increase mirtazapine plasma concentration. May require dose decrease.
- Mirtazapine + Warfarin— Monitor INR during concomitant use with mirtazapine.